139 related articles for article (PubMed ID: 8550561)
1. Biosynthesis of N-acetylsphingosine by platelet-activating factor: sphingosine CoA-independent transacetylase in HL-60 cels.
Lee TC; Ou MC; Shinozaki K; Malone B; Snyder F
J Biol Chem; 1996 Jan; 271(1):209-17. PubMed ID: 8550561
[TBL] [Abstract][Full Text] [Related]
2. Purification and characterization from rat kidney membranes of a novel platelet-activating factor (PAF)-dependent transacetylase that catalyzes the hydrolysis of PAF, formation of PAF analogs, and C2-ceramide.
Karasawa K; Qiu X; Lee T
J Biol Chem; 1999 Mar; 274(13):8655-61. PubMed ID: 10085103
[TBL] [Abstract][Full Text] [Related]
3. Acetylation of sphingosine by PAF-dependent transacetylase.
Lee T
Adv Exp Med Biol; 1996; 416():113-9. PubMed ID: 9131136
[TBL] [Abstract][Full Text] [Related]
4. A novel CoA-independent transacetylase produces the ethanolamine plasmalogen and acyl analogs of platelet-activating factor (PAF) with PAF as the acetate donor in HL-60 cells.
Lee TC; Uemura Y; Snyder F
J Biol Chem; 1992 Oct; 267(28):19992-20001. PubMed ID: 1400315
[TBL] [Abstract][Full Text] [Related]
5. Differential regulation of three catalytic activities of platelet-activating factor (PAF)-dependent transacetylase.
Lee T; Malone B; Longobardi L; Balestrieri ML
Arch Biochem Biophys; 2001 Mar; 387(1):41-6. PubMed ID: 11368182
[TBL] [Abstract][Full Text] [Related]
6. The role of platelet-activating factor-dependent transacetylase in the biosynthesis of 1-acyl-2-acetyl-sn-glycero-3-phosphocholine by stimulated endothelial cells.
Balestrieri ML; Servillo L; Lee T
J Biol Chem; 1997 Jul; 272(28):17431-7. PubMed ID: 9211886
[TBL] [Abstract][Full Text] [Related]
7. Platelet-activating factor acetylhydrolase and transacetylase activities in human plasma low-density lipoprotein.
Tsoukatos DC; Liapikos TA; Tselepis AD; Chapman MJ; Ninio E
Biochem J; 2001 Jul; 357(Pt 2):457-64. PubMed ID: 11439095
[TBL] [Abstract][Full Text] [Related]
8. Lipid acetylation reactions and the metabolism of platelet-activating factor.
Baker RR
Neurochem Res; 2000 May; 25(5):677-83. PubMed ID: 10905630
[TBL] [Abstract][Full Text] [Related]
9. Sphingolipid metabolic changes during chiral C2-ceramides induced apoptosis in human leukemia cells.
Baek MY; Yoo HS; Nakaya K; Moon DC; Lee YM
Arch Pharm Res; 2001 Apr; 24(2):144-9. PubMed ID: 11339634
[TBL] [Abstract][Full Text] [Related]
10. Platelet-activating factor (PAF)-dependent transacetylase and its relationship with PAF acetylhydrolases.
Bae K; Longobardi L; Karasawa K; Malone B; Inoue T; Aoki J; Arai H; Inoue K; Lee T
J Biol Chem; 2000 Sep; 275(35):26704-9. PubMed ID: 10867005
[TBL] [Abstract][Full Text] [Related]
11. A novel enzyme that catalyzes the esterification of N-acetylsphingosine. Metabolism of C2-ceramides.
Abe A; Shayman JA; Radin NS
J Biol Chem; 1996 Jun; 271(24):14383-9. PubMed ID: 8662981
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of acyl-CoA:cholesterol acyltransferase in Chinese hamster ovary (CHO) cells by short-chain ceramide and dihydroceramide.
Ridgway ND
Biochim Biophys Acta; 1995 Apr; 1256(1):39-46. PubMed ID: 7742354
[TBL] [Abstract][Full Text] [Related]
13. On the presence of C2-ceramide in mammalian tissues: possible relationship to etherphospholipids and phosphorylation by ceramide kinase.
Van Overloop H; Denizot Y; Baes M; Van Veldhoven PP
Biol Chem; 2007 Mar; 388(3):315-24. PubMed ID: 17338639
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of non-natural C2-homo-ceramide and its apoptotic activity against HL-60 cells.
Shikata K; Niiro H; Azuma H; Tachibana T; Ogino K
Bioorg Med Chem Lett; 2003 Feb; 13(4):613-6. PubMed ID: 12639542
[TBL] [Abstract][Full Text] [Related]
15. Interaction of ceramides, sphingosine, and sphingosine 1-phosphate in regulating DNA synthesis and phospholipase D activity.
Gómez-Muñoz A; Waggoner DW; O'Brien L; Brindley DN
J Biol Chem; 1995 Nov; 270(44):26318-25. PubMed ID: 7592842
[TBL] [Abstract][Full Text] [Related]
16. Regulation of the biosynthesis of acyl analogs of platelet-activating factor by purinergic agonist in endothlial cells.
Balestrieri ML; Lee T
FEBS Lett; 2000 Aug; 479(1-2):63-6. PubMed ID: 10940389
[TBL] [Abstract][Full Text] [Related]
17. Structural requirements of ceramide and sphingosine based inhibitors of mitochondrial ceramidase.
Usta J; El Bawab S; Roddy P; Szulc ZM; Yusuf ; Hannun A; Bielawska A
Biochemistry; 2001 Aug; 40(32):9657-68. PubMed ID: 11583166
[TBL] [Abstract][Full Text] [Related]
18. MgATP has different inhibitory effects on the use of 1-acyl-lysophosphatidylcholine and lyso platelet-activating factor acceptors by neuronal nuclear acetyltransferase activities.
Baker RR; Chang H
Biochim Biophys Acta; 1998 Jun; 1392(2-3):351-60. PubMed ID: 9630721
[TBL] [Abstract][Full Text] [Related]
19. Phosphatidate phosphohydrolase catalyzes the hydrolysis of ceramide 1-phosphate, lysophosphatidate, and sphingosine 1-phosphate.
Waggoner DW; Gómez-Muñoz A; Dewald J; Brindley DN
J Biol Chem; 1996 Jul; 271(28):16506-9. PubMed ID: 8663293
[TBL] [Abstract][Full Text] [Related]
20. Types of purinoceptors and phospholipase A2 involved in the activation of the platelet-activating factor-dependent transacetylase activity and arachidonate release by ATP in endothelial cells.
Balestrieri ML; Malik KU; Balestrieri C; Lee TC
Prostaglandins Other Lipid Mediat; 1998 Aug; 56(5-6):363-75. PubMed ID: 9990678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
